Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Buckner

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Chemical Reviews|November 4, 2014
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasisAdvait S Nagle, Shilpi Khare, Arun Babu Kumar, et al.
Journal of Medicinal Chemistry|August 9, 2008
Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validationSteven Fletcher, Christopher G Cummings, Kasey Rivas, et al.
Microbiology Spectrum|March 11, 2026
<i>In vitro</i> activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infectionsJohn Domagala, Seyedhameneh Jahanbakhsh, Angela K Mendez, et al.
Journal of Structural Biology|May 5, 2010
The structure of tryptophanyl-tRNA synthetase from Giardia lamblia reveals divergence from eukaryotic homologsTracy L Arakaki, Megan Carter, Alberto J Napuli, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 10, 2008
Structure of a Trypanosoma brucei alpha/beta-hydrolase fold protein with unknown functionEthan A Merritt, Margaret Holmes, Frederick S Buckner, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ranae M Ranade, et al.
Structure (London, England : 1993)|August 21, 2012
Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selectionCho Yeow Koh, Jessica E Kim, Sayaka Shibata, et al.
Microbiology Spectrum|September 9, 2024
Descriptive and molecular epidemiology of leishmaniasis diagnosed from clinical samples in the United States, 2021-2022Thao T Truong, Karissa Crawford, Ichih Wang-McGuire, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 8, 2015
A binding hotspot in Trypanosoma cruzi histidyl-tRNA synthetase revealed by fragment-based crystallographic cocktail screensCho Yeow Koh, Latha Kallur Siddaramaiah, Ranae M Ranade, et al.
ACS Infectious Diseases|January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African TrypanosomiasisWilliam G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Chemical Reviews|November 4, 2014
Recent developments in drug discovery for leishmaniasis and human African trypanosomiasisAdvait S Nagle, Shilpi Khare, Arun Babu Kumar, et al.
Journal of Medicinal Chemistry|August 9, 2008
Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamine-analogue scaffolds and homology model validationSteven Fletcher, Christopher G Cummings, Kasey Rivas, et al.
Microbiology Spectrum|March 11, 2026
<i>In vitro</i> activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infectionsJohn Domagala, Seyedhameneh Jahanbakhsh, Angela K Mendez, et al.
Journal of Structural Biology|May 5, 2010
The structure of tryptophanyl-tRNA synthetase from Giardia lamblia reveals divergence from eukaryotic homologsTracy L Arakaki, Megan Carter, Alberto J Napuli, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|June 10, 2008
Structure of a Trypanosoma brucei alpha/beta-hydrolase fold protein with unknown functionEthan A Merritt, Margaret Holmes, Frederick S Buckner, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2017
Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ranae M Ranade, et al.
Structure (London, England : 1993)|August 21, 2012
Distinct states of methionyl-tRNA synthetase indicate inhibitor binding by conformational selectionCho Yeow Koh, Jessica E Kim, Sayaka Shibata, et al.
Microbiology Spectrum|September 9, 2024
Descriptive and molecular epidemiology of leishmaniasis diagnosed from clinical samples in the United States, 2021-2022Thao T Truong, Karissa Crawford, Ichih Wang-McGuire, et al.
Acta Crystallographica. Section D, Biological Crystallography|August 8, 2015
A binding hotspot in Trypanosoma cruzi histidyl-tRNA synthetase revealed by fragment-based crystallographic cocktail screensCho Yeow Koh, Latha Kallur Siddaramaiah, Ranae M Ranade, et al.
ACS Infectious Diseases|January 24, 2017
From Cells to Mice to Target: Characterization of NEU-1053 (SB-443342) and Its Analogues for Treatment of Human African TrypanosomiasisWilliam G Devine, Rosario Diaz-Gonzalez, Gloria Ceballos-Perez, et al.
Pageof 12